SEC Form 4 · accession 0001171843-17-005464
Sucampo Pharmaceuticals, Inc. · SCMP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jason Patrick Meyenburg
Officer — Chief Commercial Officer
Period of report
Sep 6, 2017
Accepted (ET)
Sep 8, 2017 · 4:40 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001365216
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, Class A | Sep 6, 2017 | P | 4,000 | $12.125 | A | 30,228 | D |
Table II — derivative securities
No Table II lines on this filing.